Sector
DiversifiedOpen
₹1,732.7Prev. Close
₹1,732.7Turnover(Lac.)
₹37.06Day's High
₹1,738.95Day's Low
₹1,682.0552 Week's High
₹1,805.952 Week's Low
₹1,101.2Book Value
₹727.57Face Value
₹10Mkt Cap (₹ Cr.)
2,441.58P/E
38.54EPS
44.94Divi. Yield
0.58Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 14.13 | 14.13 | 14.13 | 14.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 986.79 | 939.25 | 315.5 | 280.52 |
Net Worth | 1,000.92 | 953.38 | 329.63 | 294.65 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 636.52 | 645.76 | 577.54 | 532.73 |
yoy growth (%) | -1.43 | 11.81 | 8.41 | 2.67 |
Raw materials | -251.73 | -260.02 | -241.59 | -243.24 |
As % of sales | 39.54 | 40.26 | 41.83 | 45.66 |
Employee costs | -160.07 | -143.94 | -108.98 | -88.1 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 28.95 | 19.42 | 30.14 | 30.05 |
Depreciation | -13.71 | -14.37 | -15.24 | -11.86 |
Tax paid | 9.38 | -7.1 | -11.98 | -10.72 |
Working capital | 49.33 | 19.85 | 65.62 | 8.39 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -1.43 | 11.81 | 8.41 | 2.67 |
Op profit growth | 23.3 | -33.49 | 8.22 | -2.86 |
EBIT growth | 37.38 | -34.93 | 5.13 | -14.62 |
Net profit growth | 276.97 | -32.18 | -6.04 | -14.69 |
Particulars (Rupees in Crores.) | Mar-2003 |
---|---|
Gross Sales | 147.17 |
Excise Duty | 0 |
Net Sales | 147.17 |
Other Operating Income | 0 |
Other Income | 1.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
3M India Ltd 3MINDIA | 35,098.75 | 69.94 | 39,590.89 | 146.48 | 1.95 | 995.04 | 2,103.1 |
Swan Energy Ltd SWANENERGY | 623.4 | 0 | 19,550.31 | 3.25 | 0.02 | 39.46 | 145.73 |
DCM Shriram Ltd DCMSHRIRAM | 1,123.05 | 37.37 | 17,523.24 | 93.66 | 0.59 | 2,804.88 | 422.01 |
Nava Ltd NAVA | 977.5 | 51.06 | 14,187.94 | 131.06 | 0.41 | 517.86 | 252.37 |
Quess Corp Ltd QUESS | 799.7 | 27.65 | 11,890.8 | 85.55 | 1.25 | 4,211.94 | 180.93 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
T T Raghunathan
Non-Exec & Non-Independent Dir
R K Tulshan
Non-Exec & Non-Independent Dir
K Shankaran
Whole Time Director & Secretar
S Kalyanaraman
Non-Exec. & Independent Dir.
Vandana R Walvekar
Non-Exec. & Independent Dir.
Girish Rao
Non-Exec. & Independent Dir.
S Balasubramanian
Non-Exec. & Independent Dir.
N Ramesh Rajan
Non-Exec. & Independent Dir.
V Ranganathan
Non Executive Director
T T Mukund
Independent Director
Murali Neelakantan
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by TTK Healthcare Ltd
Summary
TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov 81. The Company is the owner of famous Woodwards Gripewater brand. The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions. It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses. In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion. Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc. It also has a consumer products and food division manufacturing kiwi shoe polishes, snacks, etc. The company has collaborations with a number of foreign corporations such as London International, Kali-Chemi, Germany; Hatu-ICO, Spain; Nicholas Kiwi, US, etc. The products of the company are exported to the UK, Egypt, the US, Germany, Singapore, Malaysia, Carribean countries, etc.The Pallavaram plant of the company has been accredited with the ISO 14002 certification by the Bureau of Indian Standards. Also, one of the group companies, TT Maps and Publications was merged with TTK Pharma in 1993.The company faced some rough weather in Jul.95 whe
Read More
The TTK Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1727.9 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of TTK Healthcare Ltd is ₹2441.58 Cr. as of 09 Sep ‘24
The PE and PB ratios of TTK Healthcare Ltd is 38.54 and 2.46 as of 09 Sep ‘24
The 52-week high/low is the highest and lowest price at which a TTK Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of TTK Healthcare Ltd is ₹1101.2 and ₹1805.9 as of 09 Sep ‘24
TTK Healthcare Ltd's CAGR for 5 Years at 30.53%, 3 Years at 34.63%, 1 Year at 48.30%, 6 Month at 12.36%, 3 Month at 21.04% and 1 Month at 10.97%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice